Search Results - "Hamilton, Jasmine L"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    In vivo efficacy, toxicity and biodistribution of ultra-long circulating desferrioxamine based polymeric iron chelator by Hamilton, Jasmine L, Imran ul-haq, Muhammad, Abbina, Srinivas, Kalathottukaren, Manu Thomas, Lai, Benjamin F.L, Hatef, Azadeh, Unniappan, Suraj, Kizhakkedathu, Jayachandran N

    Published in Biomaterials (01-09-2016)
    “…Abstract Desferrioxamine (DFO) is currently in clinical use to remove iron from transfusion-dependent patients with β-thalassemia major, sickle-cell anemia and…”
    Get full text
    Journal Article
  2. 2

    Design of Long Circulating Nontoxic Dendritic Polymers for the Removal of Iron in Vivo by Imran ul-haq, Muhammad, Hamilton, Jasmine L, Lai, Benjamin F. L, Shenoi, Rajesh A, Horte, Sonja, Constantinescu, Iren, Leitch, Heather A, Kizhakkedathu, Jayachandran N

    Published in ACS nano (23-12-2013)
    “…Patients requiring chronic red blood cell (RBC) transfusions for inherited or acquired anemias are at risk of developing transfusional iron overload, which may…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Clinically approved iron chelators influence zebrafish mortality, hatching morphology and cardiac function by Hamilton, Jasmine L, Hatef, Azadeh, Imran ul-Haq, Muhammad, Nair, Neelima, Unniappan, Suraj, Kizhakkedathu, Jayachandran N

    Published in PloS one (16-10-2014)
    “…Iron chelation therapy using iron (III) specific chelators such as desferrioxamine (DFO, Desferal), deferasirox (Exjade or ICL-670), and deferiprone (Ferriprox…”
    Get full text
    Journal Article
  5. 5

    Iron Binding and Iron Removal Efficiency of Desferrioxamine Based Polymeric Iron Chelators: Influence of Molecular Size and Chelator Density by Hamilton, Jasmine L., ul‐haq, Muhammad Imran, Creagh, A. Louise, Haynes, Charles A., Kizhakkedathu, Jayachandran N.

    Published in Macromolecular bioscience (01-03-2017)
    “…Desferrioxamine (DFO) is a clinically approved, high affinity iron chelator used for the treatment of iron overload. Due to its short half‐life and toxicity,…”
    Get full text
    Journal Article
  6. 6

    Polymeric nanocarriers for the treatment of systemic iron overload by Hamilton, Jasmine L, Kizhakkedathu, Jayachandran N

    Published in Molecular and cellular therapies (24-03-2015)
    “…Desferrioxamine (DFO), deferiprone (L1) and desferasirox (ICL-670) are clinically approved iron chelators used to treat secondary iron overload. Although iron…”
    Get full text
    Journal Article
  7. 7

    Clinically Approved Iron Chelators Influence Zebrafish Mortality, Hatching Morphology and Cardiac Function: e109880 by Hamilton, Jasmine L, Hatef, Azadeh, ul-haq, Muhammad Imran, Nair, Neelima, Unniappan, Suraj, Kizhakkedathu, Jayachandran N

    Published in PloS one (01-10-2014)
    “…Iron chelation therapy using iron (III) specific chelators such as desferrioxamine (DFO, Desferal), deferasirox (Exjade or ICL-670), and deferiprone (Ferriprox…”
    Get full text
    Journal Article